Teva Pharmaceuticals Deal History & Licensing Activity
Teva Pharmaceuticals is a large biotech headquartered in US. Over the past three years, Teva Pharmaceuticals has been involved in 2 licensing and acquisition transactions, with a primary focus on Antibodies (2 deals). The company currently has 8 active clinical trials, primarily in Dermatology.
Deals (12mo)
2
Active Trials
8
Top Modality
Antibodies
Focus Area
Dermatology
Teva Pharmaceuticals Recent Deal Activity
Licensing, acquisition, and partnership transactions involving Teva Pharmaceuticals in the past 12 months.
| Asset | Partner | Modality | Phase | Type | Date |
|---|---|---|---|---|---|
| TEV-53408 | Royalty Pharma | Antibodies | Phase 2 | license | Jan 15, 2026 |
Teva Pharmaceuticals Pipeline Focus
Therapeutic areas and modalities where Teva Pharmaceuticals is most active based on deal history and clinical trial data.
Therapeutic Areas
Teva Pharmaceuticals Clinical Pipeline
Teva Pharmaceuticals has 8 active clinical trials across 4 development phases.
2
Phase 4
4
Unknown
1
Phase 2
1
Phase 3
See How Your Asset Matches Teva Pharmaceuticals's Portfolio
Use Solidus to benchmark upfront payments, milestones, and royalties for Dermatology assets — powered by data from 3,500+ real biopharma transactions.
Related Intelligence
Dermatology Deal Benchmarks
Market sizing, deal terms, and competitive landscape for dermatology
Antibodies Benchmarks
Upfront, milestone, and royalty benchmarks for antibodies deals
Small Molecules Benchmarks
Upfront, milestone, and royalty benchmarks for small molecules deals
Deal Pulse
Track the latest biopharma licensing and acquisition deals across all therapeutic areas
All Company Profiles
Browse 850+ biotech and pharma company profiles with deal history and pipeline data
2026 Deal Benchmarks Report
About Teva Pharmaceuticals Licensing & Deal Activity
Teva Pharmaceuticals is a large biotech company based in US that has been actively engaged in licensing transactions across the biopharma landscape. With 2 deals over the past three years, Teva Pharmaceuticals ranks among the actively acquisitive companies tracked by Ambrosia Ventures.
Key therapeutic areas of focus for Teva Pharmaceuticals include Dermatology (2 deals and trials), Hematological Malignancies (2 deals and trials), Autoimmune (2 deals and trials), and Rare Disease (1 deal and trial). In terms of modality, Teva Pharmaceuticals has shown particular interest in antibodies, small molecules.
Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for Teva Pharmaceuticals and 850+ other biopharma companies. Use our Solidus to benchmark your asset against Teva Pharmaceuticals's historical deal terms, or explore all company profiles to find the best partner match for your pipeline.